CITIUS ONCOLOGY, INC. 10-K Cybersecurity GRC - 2024-04-16

Page last updated on December 27, 2024

CITIUS ONCOLOGY, INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-04-16 17:00:38 EDT.

Filings

10-K filed on 2024-04-16

CITIUS ONCOLOGY, INC. filed a 10-K at 2024-04-16 17:00:38 EDT
Accession Number: 0001493152-24-014850

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Item 1C. Cybersecurity. We are a SPAC with no business operations. Since our Initial Public Offering, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates. Therefore, we do not consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes for assessing cybersecurity risk. Our management is generally responsible for the oversight of risks from cybersecurity threats, if there is any. In fiscal year 2023, we did not identify any cybersecurity threats that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or financial condition.


Company Information

NameCITIUS ONCOLOGY, INC.
CIK0001851484
SIC DescriptionPharmaceutical Preparations
TickerCTOR - Nasdaq
Website
Category
Emerging growth company
Fiscal Year EndSeptember 29